New drug combo trial offers hope for aggressive breast cancer
NCT ID NCT07376629
Summary
This study is testing whether adding the experimental drug HB0025 to standard chemotherapy works better for people with advanced triple-negative breast cancer who haven't had previous treatment for their advanced disease. Researchers will enroll 60 participants to measure how well the combination controls the cancer and what side effects occur. The goal is to see if this approach can better manage this difficult-to-treat cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Jining Medical University
Jining, China
-
Anhui Provincial Hospital
Hefei, China
-
Anyang Cancer Hospital
Anyang, China
-
Fudan University Shanghai Cancer Center
Shanghai, China
-
Fujian Cancer Hospital
Fujian, China
-
Guangdong Provincial People's Hospital
Guangdong, China
-
Harbin Medical University Cancer Hospital
Harbin, China
-
Jiangsu Province Hospital
Nanjing, China
-
Liaoning Cancer Hospital
Shengyang, China
-
Linyi Cancer Hospital
Linyi, China
-
Shandong Cancer Hospital
Shandong, China
-
Shanxi Cancer Hospital
Shanxi, China
-
Sichuan Cancer Hospital
Chengdu, China
-
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, China
-
Sun Yat-sen University Cancer Center
Guangzhou, China
-
The First Affiliated Hospital of Xiamen University
Xiamen, China
-
The First Hospital of Jilin University
Jilin, China
-
The Second Affiliated Hospital of Soochow University
Suzhou, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
Tianjin Cancer Hospital
Tianjing, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
-
Xiangya Hospital Central South University
Changsha, China
-
Xuzhou Central Hospital
Xuzhou, China
Conditions
Explore the condition pages connected to this study.